Vascular Function, Insulin Sensitivity, and Vitamin D (VIVID)
Vitamin D, Vascular Function, and Insulin Sensitivity in Adults [The VIVID Study
The overall objectives of this study are to examine the relationships between circulating vitamin D, insulin sensitivity, and multiple indices of vascular function and to examine whether vitamin D deficiency in African Americans (AA) and White Hispanics (WH) is responsible for ethnic differences in insulin sensitivity and hypertension in AA, WH and European Americans (EA), as well as mechanisms underlying the association between insulin resistance and blood pressure. We hypothesize that 1) serum 25(OH)D is associated with insulin sensitivity and vascular functioning, independent of adiposity, 2) lower insulin sensitivity and vascular functioning in AA and WH relative to EA is due to lower circulating 25(OH)D in AA, and 3) the relationship between insulin resistance and vascular dysfunction is mediated by 25(OH)D.
Acronyms: African American (AA), European American (EA), White Hispanics (WH), Serum 25-hydroxy vitamin D (25()H)D, Body mass index (BMI), Alabama (AL).
研究概览
研究类型
注册 (实际的)
联系人和位置
学习地点
-
-
Alabama
-
Birmingham、Alabama、美国、35243
- University of Alabama
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
- Healthy adults with BMI below 32
- Both males and females
- Ages 19-60 years
- Race: African Americans, White Hispanics, European Americans
描述
Inclusion Criteria:
- African American (AA), White Hispanic (WH), and European American (EA) race
- Ages 19-60 years
- Negative urine pregnancy test
- No evidence of diabetes
- Not on medications that can affect vascular functioning or insulin sensitivity
Exclusion Criteria:
- BMI > 32 kg/m2
- Diabetes or any chronic diseases
- Use of medication(s) known to influence body composition, vascular function, or glucose metabolism
- Regular smoking
- Regular use of illegal drugs and pregnancy
学习计划
研究是如何设计的?
设计细节
队列和干预
团体/队列 |
|---|
|
Healthy adults
healthy adults with BMI below 32, between ages 19-60 yrs, both males and females
|
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
Insulin sensitivity
大体时间:Cross sectional study: at first study visit
|
Cross sectional study: at first study visit
|
次要结果测量
结果测量 |
大体时间 |
|---|---|
|
Vascular function
大体时间:Cross sectional study: at second study visit, within 2 weeks of first study visit
|
Cross sectional study: at second study visit, within 2 weeks of first study visit
|
合作者和调查者
调查人员
- 首席研究员:Ambika Ashraf, MD、University of Alabama at Birmingham
出版物和有用的链接
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (估计)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.